SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Bridge Pharmaceuticals, Inc., a global leader in preclinical drug testing with facilities in the US and China, today announced initiation of a Visiting Scholar Program for its employees. This program will provide full support for qualified US employees to relocate and cross train in Bridge’s laboratories in Beijing, China or alternatively, for its qualified China employees to cross train in its laboratories in Gaithersburg, Maryland.
